NBP

Novabridge Biosciences

-$60.0M

Net Activity

Institutions Holding

49

Popularity Rank

#6042

Avg Weight

0.13%

Total Value

$71.9M

Ownership Trend

49 institutions currently hold NBP, with 23 net buyers and 33 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

33

Net Buying Institutions

23

Key Holders

View all 49 holding institutions

Quarterly Activity

Recent Activity

+$22.4M

Total Buy Value

$64.1M

Total Sell Value

New buy8
Trim16
Add15
Sold out17

23

Net Buyers

33

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding NOVABRIDGE BIOSCIENCES (NBP)?
Major stakeholders currently include Janus Henderson Group PLC ($14.8M), Hhlr Advisors, LTD. ($14.7M), Morgan Stanley ($9.4M). Based on the latest 13F filings, there are a total of 49 tracked investment funds and institutions maintaining positions in NBP.
What is the overall institutional sentiment toward NBP recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $60.0M, driven by 23 managers accumulating shares while 33 reduced their exposure.
Which institutions have been selling or reducing their NBP positions?
In the latest period, 16 funds trimmed their holdings, and 17 managers completely exited their positions. The aggregate reported sell value was $64.1M.
Are there any notable investors adding NBP to their portfolios?
Yes, buying activity remains notable. 8 institutions opened new positions in {ticker}, and 15 existing holders added to their shares. The total reported buy value for the quarter amounted to $22.4M.

Related Stocks